The Use and Indication of Ivabradine in Heart Failure
- PMID: 30266358
- DOI: 10.1016/j.hfc.2018.06.001
The Use and Indication of Ivabradine in Heart Failure
Abstract
Heart failure affects more than 6 million people in the United States each year and the prognosis is poor. The elevated heart rate in heart failure patents is problematic, because it increases myocardial oxygen demand, decreases myocardial perfusion, and has been associated with increased rates of hospitalization and mortality. For these reasons, heart rate reduction has long been a therapeutic target in heart failure. Ivabradine is a selective inhibitor of the sinoatrial pacemaker modulating "f-current" (If) and provides heart rate reduction that can be beneficial in patients with heart failure with reduced ejection fraction.
Keywords: Goal-directed medical therapy; Heart failure; Heart failure drug therapy; Heart rate; Heart rate lowering; Ivabradine; Sinoatrial node.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Ivabradine: Heart Failure and Beyond.J Cardiovasc Pharmacol Ther. 2016 Jul;21(4):335-43. doi: 10.1177/1074248415624157. Epub 2015 Dec 31. J Cardiovasc Pharmacol Ther. 2016. PMID: 26721645 Review.
-
Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.Expert Rev Cardiovasc Ther. 2018 Jul;16(7):515-526. doi: 10.1080/14779072.2018.1489235. Epub 2018 Jul 2. Expert Rev Cardiovasc Ther. 2018. PMID: 29902387 Review.
-
Advances in the management of heart failure: the role of ivabradine.Vasc Health Risk Manag. 2016 Nov 17;12:453-470. doi: 10.2147/VHRM.S90383. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27895488 Free PMC article. Review.
-
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Lancet. 2010. PMID: 20801500 Clinical Trial.
-
Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.Drugs. 2004;64(16):1757-65. doi: 10.2165/00003495-200464160-00003. Drugs. 2004. PMID: 15301560 Review.
Cited by
-
Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future.Front Cardiovasc Med. 2024 Mar 19;11:1337154. doi: 10.3389/fcvm.2024.1337154. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38566963 Free PMC article. Review.
-
Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives.Cureus. 2019 Apr 13;11(4):e4448. doi: 10.7759/cureus.4448. Cureus. 2019. PMID: 31205834 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical